14 October 2020
This alert was created automatically by our award-winning intelligence product Silobreaker Online. Story selection is determined by an algorithm and based on queries initially set by a Silobreaker user. Contact us here for more information.
- Around the world in 80 seconds: Cristiano Ronaldo tests positive for Covid-19, a WWII bomb explodes in Poland, & more (CNBC)
- As the UK adopts new measures to tackle coronavirus surge, what is happening in the rest of Europe? (Telegraph)
- Coronavirus infections surge in Argentina (Deutsche Welle)
- Denmark culls 2.5 million mink amid outbreak on dozens of fur farms (The Independent)
- Effective mitigation strategy in early stage of COVID-19 pandemic in China (Prevention Web)
- First death from Covid-19 reinfection reported in the Netherlands (Telegraph)
- India set to open schools, cinema halls even as nearly 7.2 million infected with Covid-19 (The Straits Times All News)
- LATEST: Friday could bring new coronavirus restrictions to Belgium (Politico.eu)
- Mark Rutte announces shops closures as Netherlands goes into partial lockdown (Mail Online UK)
- Mexico’s coronavirus death tally rises to 84,420 (NationalPost.com)
- New awareness campaign in India to fight pandemic fatigue (The Straits Times All News)
- Norway to provide COVID-19 vaccine free of charge (Mail Online UK)
- Russia: 239 people die of coronavirus past 24 hours (Kuwait News Agency)
- Saudi Arabia pioneering coronavirus research (Gulf News)
- Schools Reopen in Argentina (Bloomberg)
- South Africa has now lost more than 18 000 people to the pandemic (Comaro Chronicle)
- Teacher stuck in a Covid quarantine in Italy is allowed to return home (itv.com)
- The latest numbers on COVID-19 in Canada (NationalPost.com)
- UK – Boris Johnson has split from his top scientists on coronavirus (CNN)
- UK – Boris Johnson jokes virus restrictions will spare public Christmas with the in-laws, report claims (The Independent)
- UK – Incompetence and political misjudgements still jeopardise Boris Johnson’s strategy (The Independent)
- UK – Matt Hancock dismisses possibility of Covid-19 herd immunity (Mail Online UK)
- UK – Under-fire test and trace system is envy of the world, Matt Hancock claims (The Independent)
- US – 10 counties improve in California’s COVID-19 opening tiers. Little change for other 48 (Fresno Bee)
- US – 25-year-old Nevada man first in US to contract coronavirus twice (The Independent)
- US – COVID-19 hospitalizations up 80% in Michigan (Detroit Free Press)
- US – Colorado in “third wave” of COVID-19 as hospitalizations reach highest level since May, state health director says (Denver Post)
- US – Coronavirus in Wisconsin: Third prison in Wisconsin reports virus outbreak (Milwaukee Journal Sentinel)
- US – Daily coronavirus updates: Connecticut reports highest positivity rate since June (Hartford Courant)
- US – Humanigen’s lenzilumab selected for COVID-19 study initiated by NIH (Seeking Alpha)
- US – Indiana virus hospitalizations jump as mask order step nears (star-telegram.com)
- US – Laurie Garrett says lack of CDC briefings during this pandemic is ‘staggering’ (Washington Post)
- US – McConnell promises U.S. Senate vote on stripped-down coronavirus relief package (NationalPost.com)
- US – Ohio virus numbers continue to increase, DeWine warns (Dayton Daily News)
- US – Positive virus tests, hospitalizations surge in Colorado (Washington Times)
- US – The Trump administration’s race to get a coronavirus vaccine means Americans may not know which treatment works best (Business Insider)
- US – U.S. government signs deal to make more COVID-19 vaccine components (Reuters)
- US – Utah officials announce new pandemic strategy, mask mandates (Washington Times)
- Verheul ready to take on Portugal (Germiston City News)
- Virus curfews in effect in Germany (France24)
- WHO’s latest situation report (WHO)
- ‘Uncertain times’: BHP warns trade tensions adding to COVID-19 pain (TheAge.com)
- ADIB sees high adoption and usage of digital banking services since onset of COVID-19 (Zawya.com)
- ASML Expects Low Double-Digit Growth Next Year, Resumes Buybacks (Bloomberg-Quint)
- Amazon’s German workers launch Prime Day strike over pandemic pay (Fortune)
- Bunzl sees stronger second-half growth as Q3 revenue rises (Shares Magazine)
- Clover strike ‘should not interrupt operations’ (Citizen.co.za)
- Controversy over free ‘nowhere’ flight in Hong Kong for influencers amid looming Cathay Pacific job cuts, environmental backlash (Yahoo! Singapore)
- DNB More Leveraged Than Other Nordics To Healthy Ongoing Commercial Loan Demand (Seeking Alpha)
- FirstRand’s Chairman on the effects of Covid-19 and fixing SA’s economy (567 CapeTalk)
- Garmin teams up with Children’s Mercy Kansas City to keep children active during COVID-19 (Ariva.de)
- How to send money abroad in minutes with Standard Bank’s MoneyGram (IOL)
- Hugo Boss Wants To Break $8.3M Lease In NYC Due To Virus (Law360)
- J&J exec on coronavirus vaccine study pause: Will let science dictate how we proceed (FOX Business – Video)
- JPMorgan Chase Stock Down After Earnings — What Can Lift the Stock? (TheStreet.com)
- JPMorgan posts earnings beat during Q3; coronavirus credit losses smaller than expected (Yahoo! Canada)
- Jet2, Ryanair, easyJet and Tui latest updates on flights and cancellations (Liverpool Echo)
- Johnson & Johnson Posts Earnings Beat, Lifts 2020 Guidance (TheStreet.com)
- Johnson & Johnson interrupts COVID-19 vaccine studies (Agência Brasil)
- Johnson & Johnson pauses trial of COVID vaccine on same day U-M announces partnership (Detroit Free Press)
- Johnson & Johnson’s Covid-19 vaccine trial could resume shortly, company executives said—but first outside research… https://t.co/tGlo7JEsC2 (WSJ – Twitter)
- Korean Air extends paid leave until December on pandemic (Korea Herald)
- Maersk to lay off 2,000 in major revamp (Business Times Singapore)
- Nippon Steel considers sale of two U.S. plants in global restructuring (Japan Times)
- Nippon Steel eyes sale of 2 US plants in global restructuring (Mainichi JP)
- Nothing unusual about Johnson & Johnson halting Covid-19 vaccine trial – experts (The Star SA)
- Petrobras Hits Record September S-10 Diesel Despite Coronavirus (Zacks.com)
- Rabobank: “Where We Stand Today In The Battleground States Is Almost Exactly Where We Were In 2016” (Zero Hedge)
- Regeneron’s Coronavirus October Surprise (WSJ.com Opinion)
- Skandinaviska Enskilda Banken’s Reliance On Healthy Corporate Activity Is A Risk Factor To Watch (Seeking Alpha)
- SoftBank Resumes Buybacks With Modest $380 Million in September (Bloomberg-Quint)
- SoftBank restarted buybacks in September (Today Online)
- Tencent Plans to Lift Stake in Vivendi’s Universal Music (Bloomberg-Quint)
- Thailand to make and supply AstraZeneca COVID jab (The Phuket News)
- Wipro resumes guidance, approves ₹9,500 crore share buyback (Livemint.com)
- Wipro resumes guidance; expects to clock 1.5-3.5% growth in Q3 (Business Today India)
- COVID-19 in New Zealand and the impact of the national response: a descriptive epidemiological study (Lancet)
- Chief scientist behind Operation Warp Speed ‘extremely worried’ over politicization of coronavirus vaccine (FOXNews.com)
- Doctor: Pauses of COVID-19 clinical trials are routine (CBS News)
- First wave of COVID vaccines ‘unlikely to end pandemic’ (Sky News Latest)
- Johnson & Johnson pauses coronavirus vaccine trial following ‘unexplained illness’ in participant (FOXNews.com)
- More than 500 Dorset residents to take part in coronavirus vaccine research (itv.com)
- Nightlife clusters of coronavirus disease in Tokyo between March and April 2020 (Epidemiology & Infection – Cambridge Core)
- Oral coronavirus vaccine candidate enters clinical trial (FOXNews.com)
- Pfizer will enroll children as young as 12 in its COVID-19 vaccine trials (Mail Online UK)
- Positive coronavirus test followed by negative antibody test is not proof the virus is a lie (Reuters)
- Trials for EIi Lilly’s coronavirus antibody treatment paused (Mail Online UK)
- Vaccine trial paused as Covid-19 cases surge in US (CNN)
Although Silobreaker has relied on what it regards as reliable sources while compiling the content herein, Silobreaker cannot guarantee the accuracy, completeness, integrity or quality of such content and no responsibility is accepted by Silobreaker in respect of such content. Readers must determine for themselves what reliance they should place on the compiled content herein.